Contact
Please use this form to send email to PR contact of this press release:
hVIVO notes the initiation of a Phase I clinical trial with AGS-v, a mosquito-borne disease vaccine candidate
TO:
Please use this form to send email to PR contact of this press release:
hVIVO notes the initiation of a Phase I clinical trial with AGS-v, a mosquito-borne disease vaccine candidate
TO: